Bio-key International (BKYI) Fundamental Analysis: Revenue, Earnings & Valuation

3.07 / 10

Netural

BKYI's fundamentals are lackluster (score 3.1/10). Key weaknesses include negative asset-to-market and profit-to-market ratios, a high inventory turnover period (94.66 days), and a negative return on total assets (-29.86%). While some factors such as Net Income-to-Revenue and Inventory turnover days score positively, the overall picture suggests limited intrinsic strength. Investors should be wary of the company's financial leverage and asset efficiency.

Analysis Checks(6/10)

Revenue-MV

Value0.04

Score1/3

Weight1.63%

1M Return0.65%

Days sales outstanding

Value46.66

Score2/3

Weight5.18%

1M Return1.73%

Profit-MV

Value0.46

Score2/3

Weight16.00%

1M Return6.09%

Net income-Revenue

Value-0.17

Score3/3

Weight15.40%

1M Return5.64%

PB-ROE

Value-0.56

Score2/3

Weight17.44%

1M Return6.63%

Rate of return on total assets (%)

Value-29.86

Score1/3

Weight2.81%

1M Return0.99%

Annualized return on total assets (%)

Value-39.82

Score1/3

Weight2.81%

1M Return0.99%

Asset-MV

Value-0.50

Score1/3

Weight17.10%

1M Return5.65%

Inventory turnover days

Value94.66

Score3/3

Weight4.37%

1M Return1.44%

Cash-MV

Value-0.07

Score2/3

Weight17.25%

1M Return6.93%

Is BKYI undervalued or overvalued?

BKYI scores 3.07/10 on fundamentals and holds a Fair valuation at present. Backed by its -58.44% ROE, -67.34% net margin, -1.69 P/E ratio, 1.19 P/B ratio, and 85.27% earnings growth, these metrics solidify its Netural investment rating.